{
    "2018-01-10": [
        [
            {
                "time": "2018-01-09",
                "original_text": "【医药-恒瑞医药(600276)】江琦：BTK抑制剂授权海外，创新药国际化再下一城-20180109",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "BTK抑制剂",
                        "授权海外",
                        "创新药",
                        "国际化"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "【晨会聚焦】创新药龙头的投资机会如何？",
                "features": {
                    "keywords": [
                        "创新药",
                        "龙头",
                        "投资机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}